Literature DB >> 32250357

Slicing and Culturing Pig Hearts under Physiological Conditions.

Qinghui Ou1, Riham R E Abouleisa1, Xian-Liang Tang1, Hamzah R Juhardeen1, Moustafa H Meki2, Jessica M Miller2, Guruprasad Giridharan2, Ayman El-Baz2, Roberto Bolli1, Tamer M A Mohamed3.   

Abstract

Many novel drugs fail in clinical studies due to cardiotoxic side effects as the currently available in vitro assays and in vivo animal models poorly predict human cardiac liabilities, posing a multi-billion-dollar burden on the pharmaceutical industry. Hence, there is a worldwide unmet medical need for better approaches to identify drug cardiotoxicity before undertaking costly and time consuming 'first in man' trials. Currently, only immature cardiac cells (human induced pluripotent stem cell-derived cardiomyocytes [hiPSC-CMs]) are used to test therapeutic efficiency and drug toxicity as they are the only human cardiac cells that can be cultured for prolonged periods required to test drug efficacy and toxicity. However, a single cell type cannot replicate the phenotype of the complex 3D heart tissue which is formed of multiple cell types. Importantly, the effect of drugs needs to be tested on adult cardiomyocytes, which have different characteristics and toxicity responses compared to immature hiPSC-CMs. Culturing human heart slices is a promising model of intact human myocardium. This technology provides access to a complete multicellular system that mimics the human heart tissue and reflects the physiological or pathological conditions of the human myocardium. Recently, through optimization of the culture media components and the culture conditions to include continuous electrical stimulation at 1.2 Hz and intermittent oxygenation of the culture medium, we developed a new culture system setup that preserves viability and functionality of human and pig heart slices for 6 days in culture. In the current protocol, we are detailing the method for slicing and culturing pig heart as an example. The same protocol is used to culture slices from human, dog, sheep, or cat hearts. This culture system has the potential to become a powerful predictive human in situ model for acute cardiotoxicity testing that closes the gap between preclinical and clinical testing results.

Entities:  

Mesh:

Year:  2020        PMID: 32250357      PMCID: PMC7388059          DOI: 10.3791/60913

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.424


  20 in total

1.  Novel in vitro cardiovascular constructs composed of vascular-like networks and cardiomyocytes.

Authors:  Hanna Vuorenpää; Liisa Ikonen; Kirsi Kujala; Outi Huttala; Jertta-Riina Sarkanen; Timo Ylikomi; Katriina Aalto-Setälä; Tuula Heinonen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-10-26       Impact factor: 2.416

Review 2.  Cardiovascular Toxic Effects of Targeted Cancer Therapies.

Authors:  Javid J Moslehi
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

3.  The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.

Authors:  Steven P Jones; Xian-Liang Tang; Yiru Guo; Charles Steenbergen; David J Lefer; Rakesh C Kukreja; Maiying Kong; Qianhong Li; Shashi Bhushan; Xiaoping Zhu; Junjie Du; Yibing Nong; Heather L Stowers; Kazuhisa Kondo; Gregory N Hunt; Traci T Goodchild; Adam Orr; Carlos C Chang; Ramzi Ockaili; Fadi N Salloum; Roberto Bolli
Journal:  Circ Res       Date:  2014-12-11       Impact factor: 17.367

Review 4.  Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes.

Authors:  Claire Robertson; David D Tran; Steven C George
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

5.  Anatomy of the pig heart: comparisons with normal human cardiac structure.

Authors:  S J Crick; M N Sheppard; S Y Ho; L Gebstein; R H Anderson
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

6.  Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart.

Authors:  Xing Fu; Hadi Khalil; Onur Kanisicak; Justin G Boyer; Ronald J Vagnozzi; Bryan D Maliken; Michelle A Sargent; Vikram Prasad; Iñigo Valiente-Alandi; Burns C Blaxall; Jeffery D Molkentin
Journal:  J Clin Invest       Date:  2018-04-16       Impact factor: 14.808

7.  Profiling proliferative cells and their progeny in damaged murine hearts.

Authors:  Kai Kretzschmar; Yorick Post; Marie Bannier-Hélaouët; Andrea Mattiotti; Jarno Drost; Onur Basak; Vivian S W Li; Maaike van den Born; Quinn D Gunst; Danielle Versteeg; Lieneke Kooijman; Stefan van der Elst; Johan H van Es; Eva van Rooij; Maurice J B van den Hoff; Hans Clevers
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-07       Impact factor: 11.205

8.  Comparative study of the effects of fetal bovine serum versus horse serum on growth and differentiation of primary equine bronchial fibroblasts.

Authors:  Jana Franke; Vanessa Abs; Claudia Zizzadoro; Getu Abraham
Journal:  BMC Vet Res       Date:  2014-05-26       Impact factor: 2.741

Review 9.  Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature.

Authors:  Igho J Onakpoya; Carl J Heneghan; Jeffrey K Aronson
Journal:  BMC Med       Date:  2016-02-04       Impact factor: 8.775

10.  Investigation of cardiac fibroblasts using myocardial slices.

Authors:  Filippo Perbellini; Samuel A Watson; Martina Scigliano; Samha Alayoubi; Sebastian Tkach; Ifigeneia Bardi; Nicholas Quaife; Christopher Kane; Neil P Dufton; André Simon; Markus B Sikkel; Giuseppe Faggian; Anna M Randi; Julia Gorelik; Sian E Harding; Cesare M Terracciano
Journal:  Cardiovasc Res       Date:  2018-01-01       Impact factor: 10.787

View more
  3 in total

1.  Editorial: Recent Advances in Cardiotoxicity Testing.

Authors:  Tamer M A Mohamed; Javid Moslehi; Jonathan Satin
Journal:  Front Pharmacol       Date:  2021-11-08       Impact factor: 5.810

2.  Biomimetic cardiac tissue culture model (CTCM) to emulate cardiac physiology and pathophysiology ex vivo.

Authors:  Jessica M Miller; Moustafa H Meki; Ahmed Elnakib; Qinghui Ou; Riham R E Abouleisa; Xian-Liang Tang; Abou Bakr M Salama; Ahmad Gebreil; Cindy Lin; Hisham Abdeltawab; Fahmi Khalifa; Bradford G Hill; Najah Abi-Gerges; Roberto Bolli; Ayman S El-Baz; Guruprasad A Giridharan; Tamer M A Mohamed
Journal:  Commun Biol       Date:  2022-09-09

3.  Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity.

Authors:  Jessica M Miller; Moustafa H Meki; Qinghui Ou; Sharon A George; Anna Gams; Riham R E Abouleisa; Xian-Liang Tang; Brooke M Ahern; Guruprasad A Giridharan; Ayman El-Baz; Bradford G Hill; Jonathan Satin; Daniel J Conklin; Javid Moslehi; Roberto Bolli; Alexandre J S Ribeiro; Igor R Efimov; Tamer M A Mohamed
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-30       Impact factor: 4.460

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.